Elior - comment

A share buyback of up to €252m over the next 18 months is an eye-catching headline, but we expect the actual buyback outlay will be much smaller and back-ended. The buyback authorisation figure is sized on 10% of outstanding shares at €10 per share, bu

Read More
Aengus McMahonELIOR
Oriflame - In the Mix

Please find our updated analysis of Oriflame here.

So the Felix household bought a blender the other day. It’s a great way to fix up smoothies in no time and it’s striking to see the ingredients blend to the point where they are no longer recognisable. In a way, Oriflame results in the last six months have been strikingly

Read More
Ocado - comment

Y23 results were ahead of our model and above the median of analyst consensus. Overall, we see the results as a positive development for the Tech Solutions business, and the end game for

Read More
Aengus McMahonOCADO